참고문헌
- Abe, S., Y. Sato, S. Inoue, H. Ishibashi, N. Maruyama, T. Takizawa, H. Oshima, and H. Yamaguchi. 2003. Anti-Candida albicans activity of essential oils including lemongrass (Cymbopogon citratus) oil and its component, citral. Nippon Ishinkin Gakkai Zasshi 44: 285-291. https://doi.org/10.3314/jjmm.44.285
- Abe, S., T. Satoh, Y. Tokuda, S. Tansho, and H. Yamaguchi. 1994. A rapid colorimetric assay for determination of leukocytemediated inhibition of mycelial growth of Candida albicans. Microbiol. Immunol. 38: 385-388. https://doi.org/10.1111/j.1348-0421.1994.tb01795.x
- Baur, J. A. and D. A. Sinclair. 2006. Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 5: 493-506. https://doi.org/10.1038/nrd2060
- Bhat, K. P. and J. M. Pezzuto. 2002. Cancer chemopreventive activity of resveratrol. Ann. NY Acad. Sci. 957: 210-229. https://doi.org/10.1111/j.1749-6632.2002.tb02918.x
- de Repentigny, L., D. Lewandowski, and P. Jolicoeur. 2004. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin. Microbiol. Rev. 17: 729-759. https://doi.org/10.1128/CMR.17.4.729-759.2004
- Docherty, J. J., M. M. Fu, and M. Tsai. 2001. Resveratrol selectively inhibits Neisseria gonorrhoeae and Neisseria meningitidis. J. Antimicrob. Chemother. 47: 243-244. https://doi.org/10.1093/jac/47.2.243
- Donnelly, L. E., R. Newton, G. E. Kennedy, P. S. Fenwick, R. H. Leung, K. Ito, R. E. Russell, and P. J. Barnes. 2004. Antiinflammatory effects of resveratrol in lung epithelial cells: Molecular mechanisms. Am. J. Physiol. Lung Cell Mol. Physiol. 287: L774-L783. https://doi.org/10.1152/ajplung.00110.2004
- Hawser, S. 1996. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: A modified XTT tetrazolium assay using synchronised C. albicans cells. J. Med. Vet. Mycol. 34: 149-152. https://doi.org/10.1080/02681219680000231
- Ignatowicz, E. and W. Baer-Dubowska. 2001. Resveratrol, a natural chemopreventive agent against degenerative diseases. Pol. J. Pharmacol. 53: 557-569.
- Jung, H. J., I. A. Hwang, W. S. Sung, H. Kang, B. S. Kang, Y. B. Seu, and D. G. Lee. 2005. Fungicidal effect of resveratrol on human infectious fungi. Arch. Pharm. Res. 28: 557-560. https://doi.org/10.1007/BF02977758
- Jung, H. J., Y. B. Seu, and D. G. Lee. 2007. Candicidal action of resveratrol isolated from grapes on human pathogenic yeast C. albicans. J. Microbiol. Biotechnol. 17: 1324-1329.
- Kanafani, Z. A. and J. R. Perfect. 2008. Antimicrobial resistance: Resistance to antifungal agents: Mechanisms and clinical impact. Clin. Infect. Dis. 46: 120-128. https://doi.org/10.1086/524071
- Lee, S. K., H. J. Lee, H. Y. Min, E. J. Park, K. M. Lee, Y. H. Ahn, Y. J. Cho, and J. H. Pyee. 2005. Antibacterial and antifungal activity of pinosylvin, a constituent of pine. Fitoterapia 76: 258-260. https://doi.org/10.1016/j.fitote.2004.12.004
- Li, Y., C. Su, X. Mao, F. Cao, and J. Chen. 2007. Roles of Candida albicans Sfl1 in hyphal development. Eukaryot. Cell 6: 2112-2121. https://doi.org/10.1128/EC.00199-07
- Lo, H. J., J. R. Kohler, B. DiDomenico, D. Loebenberg, A. Cacciapuoti, and G. R. Fink. 1997. Nonfilamentous C. albicans mutants are avirulent. Cell 90: 939-949. https://doi.org/10.1016/S0092-8674(00)80358-X
- Odds, F. C. 1987. Candida infections: An overview. Crit. Rev. Microbiol. 15: 1-5. https://doi.org/10.3109/10408418709104444
- Ogasawara, A., N. Komaki, H. Akai, K. Hori, H. Watanabe, T. Watanabe, T. Mikami, and T. Matsumoto. 2007. Hyphal formation of Candida albicans is inhibited by salivary mucin. Biol. Pharm. Bull. 30: 284-286. https://doi.org/10.1248/bpb.30.284
- Sudbery, P., N. Gow, and J. Berman. 2004. The distinct morphogenic states of Candida albicans. Trends Microbiol. 12: 317-324. https://doi.org/10.1016/j.tim.2004.05.008
- Sanchez-Martinez, C. and J. Perez-Martin. 2002. Site-specific targeting of exogenous DNA into the genome of Candida albicans using the FLP recombinase. Mol. Genet. Genomics 268: 418-424. https://doi.org/10.1007/s00438-002-0763-5
- Watamoto, T., L. P. Samaranayake, J. A. Jayatilake, H. Egusa, H. Yatani, and C. J. Seneviratne. 2009. Effect of filamentation and mode of growth on antifungal susceptibility of Candida albicans. Int. J. Antimicrob. Agents 34: 333-339. https://doi.org/10.1016/j.ijantimicag.2009.03.008
- Weber, K., B. Schulz, and M. Ruhnke. 2009. Resveratrol and its antifungal activity against Candida species. Mycoses [In Press.]
피인용 문헌
- Styraxjaponoside A and B, Antifungal Lignan Glycosides Isolated from Styrax japonica S. et Z. vol.18, pp.4, 2010, https://doi.org/10.4062/biomolther.2010.18.4.420
- Resveratrol lacks antifungal activity against Candida albicans vol.28, pp.6, 2010, https://doi.org/10.1007/s11274-012-1042-1
- Tackling Fungal Resistance by Biofilm Inhibitors vol.60, pp.6, 2010, https://doi.org/10.1021/acs.jmedchem.6b01203
- Green Tea Polyphenols and Padma Hepaten Inhibit Candida albicans Biofilm Formation vol.2018, pp.None, 2010, https://doi.org/10.1155/2018/1690747
- Histone acetylation increases in response to ferulic, gallic, and sinapic acids acting synergistically in vitro to inhibit Candida albicans yeast‐to‐hyphae transition vol.33, pp.2, 2010, https://doi.org/10.1002/ptr.6222
- Can Leaves and Stems of Rubus idaeus L. Handle Candida albicans Biofilms? vol.13, pp.12, 2010, https://doi.org/10.3390/ph13120477
- Inhibitory Effect of Resveratrol on Candida albicans Biofilm Formation vol.62, pp.1, 2010, https://doi.org/10.2209/tdcpublication.2020-0023
- Synthesis and characterization of gold nanorods using the natural products resveratrol, gallic acid, and a purified fraction of Stryphnodendron obovatum by seedless method vol.16, pp.None, 2010, https://doi.org/10.1016/j.enmm.2021.100473